PRGO Related Analyst Ratings
-
SunTrust Starts Perrigo (PRGO) at Buy, $41 Price Target
-
Caris & Co Maintains an 'Average' on Perrigo Company (PRGO); Raises PT
-
Bank of America Maintains a 'Buy' on Perrigo Company (PRGO); Raises PT
-
Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
-
Collins Stewart Reiterates a 'Buy' Rating on Perrigo (PRGO); Raises Price Target
-
Credit Suisse Downgrades Perrigo (PRGO) to Neutral
-
William Blair Initiates Coverage on Perrigo (PRGO) with an Outperform
-
Goldman Sachs Downgrades Perrigo (PRGO) to Neutral
-
Caris Downgrades Perrigo (PRGO) to Above Average
-
Morgan Stanley Initiates Coverage on Perrigo (PRGO) with an Overweight
-
Collins Stewart Initiates Coverage on Specialty Pharma Companies
-
Credit Suisse Upgrades Perrigo (PRGO) to Outperform
-
Matrix USA Rating Changes 8/28
-
Matrix USA Rating Changes 6/3
-
Matrix USA Rating Changes 5/12
-
Matrix USA Rating Changes 5/9
-
Caris & Co Initiates Coverage on Perrigo (PRGO) with a Buy
-
Credit Suisse Initiates Coverage on Perrigo (PRGO) with a Neutral
-
Merrill Lynch Downgrades Perrigo (PRGO) to Neutral
-
Sidoti & Co Upgrades Perrigo Co (PRGO) to Buy
-
Sidoti & Co Initiates Coverage on Perrigo (PRGO) with a Neutral
-
Jim Cramer Makes Positive Comments on CHTT, MTXX & PRGO
-
Jim Cramer Highlights RAH, PRGO, DLTR on Weaker US Economy
-
Goldman Sachs Starts Perrigo Co. (PRGO) at In-Line
-
Oppenheimer Upgrades PRGO
-
KeyBanc Cuts PRGO to Hold
Back to PRGO Stock Lookup
